NATCO PHARMA LIMITED (INDIA)
Trabectedin-trabec
“Trabectedin” is the Drug / Molecule content in "Trabec". Trabectedin is a novel marine antineoplastic, tetrahydroisoquinolinealkaloid. It has a unique mechanism of action and is believed to involve the production of superoxide near the DNA strand, resulting in DNA backbone cleavage and cell apoptosis. The active substance trabectedin, is a natural product originally isolated from the Caribbean sea squirt, and is currently manufactured by total synthesis.
Indication
Trabectedin is used for the treatment of patients with advanced soft tissue sarcoma (STS) after failure of anthracyclines and ifosfamide, or for those patients who are unsuitable to receive these agents.
Note
Precaution
- Trabec is a prescription drug and should be used under proper medical guidance and advice.
Strength
1 mg
Packing
Vial
Storage
Store under refrigeration between 2°C - 8°C and protect from direct sunlight.
Was this page helpful?
Related Products
Trabectedin-trabec
Trabec
Most Viewed Products
Abiraterone acetate-xbira
Bendamustine-bendit
Bicalutamide-cassotide
Bortezomib-bortenat
Erlonat
Everolimus-evertor
Exemestane-xtane
Geftinat
Glatiramer acetate-glatimer
Ledipasvir & sofosbuvir-hepcinat lp
Lenalidomide-lenalid
Pomalidomide-pomalid
Sofosbuvir & velpatasvir-velpanat
Sorafenib-sorafenat
